Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.
about
Interventions for chronic non-hypovolaemic hypotonic hyponatraemiaEfficacy and Safety of Vasopressin Receptor Antagonists for Euvolemic or Hypervolemic Hyponatremia: A Meta-AnalysisMild Chronic Hyponatremia in the Ambulatory Setting: Significance and ManagementManagement of hyponatremia.ANG II receptor subtype 1a gene knockdown in the subfornical organ prevents increased drinking behavior in bile duct-ligated ratsClinical practice guideline on diagnosis and treatment of hyponatraemia.Vacuolar pathology in the median eminence of the hypothalamus after hyponatremia.Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.Investigating endogenous peptides and peptidases using peptidomicsThe Efficacy and Safety of Tolvaptan in Patients with Hyponatremia: A Meta-Analysis of Randomized Controlled Trials.Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats.Dysnatremias in patients with kidney disease.Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials.Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses.Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients.Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease.Management of hyponatremia in various clinical situations.Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.
P2860
Q24200705-7D168326-0F33-41A2-8711-2C61CF3135FEQ26747663-118FD3C4-D2FD-415C-A6AB-C38704D9A206Q28082901-FA426A49-5CD1-4F61-A590-FD04920217BDQ33590642-D5FEEB70-9A30-4B12-B1E9-3A6E61764F02Q34201130-9EDDFCC6-FBE6-4828-B2FA-24B496EF58BBQ34406779-32F82E77-2465-472B-B64B-9F56654FAE2FQ34779598-9C579A44-0201-4993-8DF3-A74ECD786D86Q35275760-F0CB35B6-A7CF-4AE7-8940-A6CA061A651AQ36163374-CE28F692-CCA2-4986-8E71-477D0BC8CE67Q36170197-E3D48583-B976-4753-A50F-DF03A77A9059Q36694097-810904C3-AFB0-457E-BAB2-4A5AFCCB554DQ36711459-1B6D6950-02B3-4308-B3DE-C6B50C927EB7Q37665977-EA86DE85-85C4-406D-83D7-5C133C155FE2Q37799214-0767221C-D9BE-4E8B-A736-F92B9D384B18Q37959051-ED47651A-7CBC-4971-AE0A-934D3214A417Q38008650-56E14EB7-D375-461E-8C3E-DE9E752A7608Q38256581-1C8039CB-2679-4606-9493-B9083ACBB06CQ39125114-A510A8AD-6BB4-402C-8952-246E36DF94AEQ41534781-9D1FF283-D6A4-4258-A7BD-F0F7A88B3E6AQ41887495-F141982D-0D56-4BA3-BB0C-57404BF46CF7Q42822767-C9B896DC-D224-4823-B37B-4BD891E95154Q48838600-F02D6DAE-AE33-4481-90C6-2B39B558B8FAQ54468615-9E2AB7A1-437F-4DB5-960A-B183B218DC36
P2860
Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@en
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@nl
type
label
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@en
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@nl
prefLabel
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@en
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@nl
P2093
P1476
Vasopressin receptor antagonis ...... atic review and meta-analysis.
@en
P2093
Asher Korzets
Benaya Rozen-Zvi
Dafna Yahav
Uzi Gafter
P304
P356
10.1053/J.AJKD.2010.01.013
P577
2010-06-09T00:00:00Z